U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564726) titled 'Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol' on April 27.

Brief Summary: The goal of this clinical trial is to test whether one pill that combines ezetimibe, rosuvastatin, and amlodipine can safely lower cholesterol and blood pressure in Korean adults with high blood pressure and high cholesterol.

Study Start Date: Aug. 05, 2022

Study Type: INTERVENTIONAL

Condition: Hypertension Hypercholesterolemia

Intervention: DRUG: Amlodipine

Oral tablet containing amlodipine 10 mg administered for 8 weeks.

DRUG: Ezetimibe/Rosuvastatin

Fixed-dose combination oral tabl...